January 11, 2019 — Gestational diabetes (GDM) is one of the most common complications of pregnancy. And it can be serious. As obesity rates are growing, so too is GDM’s prevalence. But new research suggests that we’re missing the mark with the first-line strategy for preventing GDM. A new study from Pennington Biomedical found that diet and exercise prescriptions […]
July 18, 2018 — For the first time ever, we have direct evidence for the long-term cardiovascular safety of an obesity medication. The drug is Belviq, also known as lorcaserin. Yesterday, Eisai released topline results for the long-awaited CAMILLIA-TIMI 61 trial. This was a five-year cardiovascular outcomes study of 12,000 patients. It was randomized and placebo controlled. CV Safety […]
October 14, 2017 — Health reporters are having fun this week with another observational study. A large analysis of prospective cohorts from all over the world found a strong association between linoleic acid and a lower risk of type 2 diabetes. So naturally, the researchers sent out a press release: Omega-6 Fats May Help Prevent Type 2 Diabetes Is […]
August 28, 2017 — It’s official as of Friday. Liraglutide (Victoza) is not only for treating type 2 diabetes and obesity. FDA now says it also effectively prevents heart attacks, strokes, and cardiovascular deaths. This new information applies to people taking it for diabetes who also have heart disease. A Dramatic, Ongoing Shift in Diabetes Care This news represents […]
July 19, 2017 — America is heading at a breakneck pace toward an awesome milestone – 100 million Americans with diabetes. According to a new CDC report, 30 million have it already. Another 84 million are well on their way. They have prediabetes – elevated blood sugar that makes it very likely for a person to develop full-blown type 2 diabetes. […]
February 23, 2017 — An impressive new three-year study of 3 mg liraglutide for obesity (Saxenda) finds that this therapy provides a large reduction in the risk of developing diabetes in people who have prediabetes. Published yesterday in Lancet, investigators found an 80% reduction in the risk of progressing to diabetes. In a post-hoc analysis, they made further assumptions […]
March 15, 2016 — Here’s a jolt. New data published by the UCLA Center for Health Policy Research suggest that 55% of people in California have either diabetes or prediabetes. The headlines generated by this study are sensational, but there’s no obvious reason to doubt the report’s accuracy. In this report, we can glimpse a future filled with chronic […]
